ASSESSMENT OF FREQUENCY OF ALLOIMMUNIZATION AND ERYTHROCYTE AUTOIMMUNIZATION IN TRANSFUSION DEPENDENT THALASSEMIA PATIENTS
Life-long red blood transfusion remains the main treatment for severe thalassemia. The development of hemolytic alloantibodies and erythrocyte autoantibodies complicated transfusion therapy in thalassemia patients. The frequency causes and prevention of this phenomenon among 80 transfused thalassem...
Main Authors: | S. Ansari, P. Voosogh S. Moshtaghian |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2008-04-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/3458 |
Similar Items
-
ASSESSMENT OF FREQUENCY OF ALLOIMMUNIZATION AND ERYTHROCYTE AUTOIMMUNIZATION IN TRANSFUSION DEPENDENT THALASSEMIA PATIENTS
by: S. Ansari, et al.
Published: (2008-05-01) -
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
by: Hari Krishan Dhawan, et al.
Published: (2014-01-01) -
Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient
by: Joseph Philip, et al.
Published: (2014-01-01) -
Red Cell Alloimmunization and Autoimmunization in Multi-Transfused Thalassemia Patients in Sulaymaniyah Province-Iraq
by: Aveen M. Raouf Abdulqader, et al.
Published: (2020-06-01) -
Curso clínico da anemia hemolítica auto-imune: um estudo descritivo Clinical course of autoimmune hemolytic anemia: an observational study
by: Maria Christina L. A. Oliveira, et al.
Published: (2006-02-01)